about
Cloning humans? Biological, ethical, and social considerationsNucleic acid therapy for lifespan prolongation: present and futureCardiovascular gene therapy for myocardial infarctionHematopoietic-stem-cell-based gene therapy for HIV diseaseGenetics of SCIDFlow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary ImmunodeficienciesMicroRNAs as therapeutic targets for lung cancerGenome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapyIntravenous injection of a foamy virus vector to correct canine SCID-X1.Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vectorPreclinical safety and efficacy of human CD34(+) cells transduced with lentiviral vector for the treatment of Wiskott-Aldrich syndrome.Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.Gene therapy finds its niche.Long-lasting production of new T and B cells and T-cell repertoire diversity in patients with primary immunodeficiency who had undergone stem cell transplantation: a single-centre experience.Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.Chromatin landscapes of retroviral and transposon integration profilesTargeted plasmid integration into the human genome by an engineered zinc-finger recombinaseClinical applications of gene therapy for primary immunodeficiencies.Advances in Gene Delivery Systems.Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.Sampling protein motion and solvent effect during ligand bindingPhysical Characterization of Gemini Surfactant-Based Synthetic Vectors for the Delivery of Linear Covalently Closed (LCC) DNA Ministrings.Development of a diverse human T-cell repertoire despite stringent restriction of hematopoietic clonality in the thymus.Cellular calibrators to quantitate T-cell receptor excision circles (TRECs) in clinical samples.Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.Gene therapy for Wiskott-Aldrich Syndrome-Long-term reconstitution and clinical benefits, but increased risk for leukemogenesis.New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cellsReduced T cell receptor excision circle levels in the colonic mucosa of microscopic colitis patients indicate local proliferation rather than homing of peripheral lymphocytes to the inflamed mucosaZinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs.Primary Immune Deficiency Treatment Consortium (PIDTC) report.In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives.Ex vivo gene transfer and correction for cell-based therapies.Stem cell self-renewal: lessons from bone marrow, gut and iPS toward clinical applications.Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa.Hematopoietic stem cell expansion and gene therapy.Homologous recombination-based gene therapy for the primary immunodeficiencies.Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?Haematopoietic stem cell transplantation for SCID patients: where do we stand?Gene therapy for heart failure: where do we stand?
P2860
Q26801506-0152E104-AF68-4469-9088-B339C652DFF0Q26861654-AE6A8828-3E53-46C4-9753-4427C174032FQ27014770-0ADE00B7-2916-43BA-8A61-A2EEF8CB4CA4Q27023434-40964A40-1436-47AD-AB61-6A7AD77EBCE9Q27499229-AB9005AB-8306-458D-818D-7541B7C02AD3Q28076919-73298984-2D3C-4B91-B1BC-3970B7232E7DQ28293733-5A29AC71-977D-49D5-8492-537DD069A43BQ28740951-2C8E65A2-E964-40AE-B383-C75C34A84861Q30409845-5D940DD5-B504-4CAA-A894-971DE7498D2AQ31131479-5F06FE52-BABC-4B01-A14F-AAFFFA7F684DQ33399943-D5A14434-D106-475B-80E2-B2CB9F79878FQ33413888-022A5323-A08A-4F1B-931E-DA1B06E8AC0EQ33881920-38D87C3A-3004-4940-A1F8-3C5A6F291059Q34163207-09899A94-EC56-4DED-B293-91BF33DA93F9Q34729193-FCFAFCEA-B2AE-4412-900E-5F91D809DDEBQ35086128-DE71BEAD-DE36-4E34-B346-EAFDC1E3791AQ35144895-DC2630F5-0BBA-4BC8-A774-3B010576373DQ35224339-9CC800D4-1DBD-4D89-9BC3-E3A08B4E1759Q35539617-C8FA66BB-5D3E-4307-A298-DECAC425C553Q35632772-09F57EAC-69EB-4615-B6F7-83071A87F58AQ35670173-567DBF6A-C4BF-4EB5-A2C2-768E3DF42FBEQ35749668-1DC239E6-0886-45CD-A1E3-45E9D428F36AQ35839684-1001AD31-C3F7-4461-82E2-55B0FED825FCQ36268546-A351ED65-7DE3-4B82-8240-90CE270AD52DQ36354454-0C0EA25D-D8E5-40B0-A924-72FD684CF4DDQ36429491-5F94A64A-C52D-4BD1-8643-523E92CE6345Q36584648-F20FA9B8-B740-41E1-9FDB-BE7F38CD83B7Q36945734-DD4A5551-E209-4301-927B-922DA3BEF3D6Q37055021-719114B8-15D0-468F-9410-FA0F27B794AFQ37118845-3D6A9485-BD42-4CC8-9231-29B78301AE06Q37649782-9ECF7F2E-A6D5-43E5-A2FD-6F4B59C735FAQ37850449-A7776634-0148-43FA-8DE6-FF0E6520C2FEQ37858878-FFB33647-D429-4059-8D5D-E304BD27A15DQ37870053-CB7C4781-B264-42BD-BE08-F323624F8A38Q37873887-F1FF9799-4E9B-4141-84F6-D1F7BF1237CEQ37945718-04B5E93F-B160-40CF-911C-6E4A2C406C2DQ37974988-6546A231-85F2-45A1-8E55-8C7F3BF60B93Q37995010-3476E98F-B6E6-444B-ACE7-75EA2A928791Q38061148-4C01EBCF-57A6-43C9-8065-B7E7F3B901DDQ38073152-3016F5A3-DA46-45C8-820D-55B7D5FFBBCB
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
20 years of gene therapy for SCID.
@ast
20 years of gene therapy for SCID.
@en
20 years of gene therapy for SCID.
@nl
type
label
20 years of gene therapy for SCID.
@ast
20 years of gene therapy for SCID.
@en
20 years of gene therapy for SCID.
@nl
prefLabel
20 years of gene therapy for SCID.
@ast
20 years of gene therapy for SCID.
@en
20 years of gene therapy for SCID.
@nl
P50
P356
P1433
P1476
20 years of gene therapy for SCID.
@en
P304
P356
10.1038/NI0610-457
P407
P577
2010-06-01T00:00:00Z